Works matching IS 0012186X AND DT 2001 AND VI 44 AND IP 12

Results: 20

5-aminoimidazole-4-carboxy-amide-1-β-D-ribofuranoside treatment ameliorates hyperglycaemia and hyperinsulinaemia but not dyslipidaemia in KKAy-CETP mice.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2180, doi. 10.1007/s001250100027

By:

Fiedler, M.;
Zierath, J. R.;
Selén, G.;
Wallberg-Henriksson, H.;
Liang, Y.;
Sakariassen, K. S.

Publication type:

Article

A choice of death – the signal-transduction of immune-mediated beta-cell apoptosis.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2115, doi. 10.1007/s001250100021

By:

Eizirik, D. L.;
Mandrup-Poulsen, T.

Publication type:

Article

The author's reply.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2239

By:

Benhamou, P. Y.;
Oberholzer, J.

Publication type:

Article

The author's reply.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2238

By:

Levy, A. P.

Publication type:

Article

An economic model of the long-term health care burden of Type II diabetes.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2140, doi. 10.1007/s001250100023

By:

Bagust, A.;
Hopkinson, P. K.;
Maier, W.;
Currie, C. J.

Publication type:

Article

Comment– to: Benhamou PY et al. (2001) Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999–2000). Diabetologia 44: 859–864.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2239, doi. 10.1007/pl00022650

By:

Malaisse, W. J.

Publication type:

Article

Human adipose tissue glucose uptake determined using [18F]-fluoro-deoxy-glucose ([18F]FDG) and PET in combination with microdialysis.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2171, doi. 10.1007/s001250100026

By:

Virtanen, K. A.;
Peltoniemi, P.;
Marjamäki, P.;
Asola, M.;
Strindberg, L.;
Parkkola, R.;
Huupponen, R.;
Knuuti, J.;
Lönnroth, P.;
Nuutila, P.

Publication type:

Article

Changes in physical activity are associated with changes in metabolic cardiovascular risk factors.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2134, doi. 10.1007/s001250100022

By:

Byberg, L.;
Zethelius, B.;
McKeigue, P. M.;
Lithell, H. O.

Publication type:

Article

Oxidative stress impairs nuclear proteins binding to the insulin responsive element in the GLUT4 promoter.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2156, doi. 10.1007/s001250100024

By:

Pessler, D.;
Rudich, A.;
Bashan, N.

Publication type:

Article

Insulin-like growth factor 2 (IGF2 ) and IGF-binding protein 1 (IGFBP1) gene variants are associated with overfeeding-induced metabolic changes.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2231, doi. 10.1007/s001250100034

By:

Ukkola, O.;
Sun, G.;
Bouchard, C.

Publication type:

Article

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2210, doi. 10.1007/s001250100031

By:

Miyazaki, Y.;
Glass, L.;
Triplitt, C.;
Matsuda, M.;
Cusi, K.;
Mahankali, A.;
Mahankali, S.;
Mandarino, L. J.;
DeFronzo, R. A.

Publication type:

Article

Clusterin expression during regeneration of pancreatic islet cells in streptozotocin-induced diabetic rats.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2192, doi. 10.1007/s001250100029

By:

Kim, B.-M.;
Han, Y.-M.;
Shin, Y.-J.;
Min, B.-H.;
Park, I.-S.

Publication type:

Article

Comment– to: W. K. Waldhausl (2001) Finally we have arrived in a new millennium. Diabetologia 44: 1–2.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2239

By:

Porta, M.

Publication type:

Article

Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2203, doi. 10.1007/s001250100030

By:

Porta, M.;
Sjoelie, A.-K.;
Chaturvedi, N.;
Stevens, L.;
Rottiers, R.;
Veglio, M.;
Fuller, J. H.

Publication type:

Article

Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2220, doi. 10.1007/s001250100032

By:

Ek, J.;
Andersen, G.;
Urhammer, S. A.;
Gæde, P. H.;
Drivsholm, T.;
Borch-Johnsen, K.;
Hansen, T.;
Pedersen, O.

Publication type:

Article

Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2107, doi. 10.1007/s001250100020

By:

Bonora, E.;
Muggeo, M.

Publication type:

Article

Comment– to: F. M. Nakhoul et al. (2001) Haptoglobin phenotype and diabetes. Diabetologia 44: 602–604.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2237

By:

Moczulski, D. K.;
Rogus, J. J.;
Krolewski, A. S.

Publication type:

Article

Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2227, doi. 10.1007/s001250100033

By:

Hashim, Y.;
Shepherd, D.;
Wiltshire, S.;
Holman, R. R.;
Levy, J. C.;
Clark, A.;
Cull, C. A.

Publication type:

Article

Islet cell autoimmunity and mitochondrial DNA mutation in Korean subjects with typical and atypical Type I diabetes.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2187, doi. 10.1007/s001250100028

By:

Lee, W. J.;
Lee, H. W.;
Palmer, J. P.;
Park, K. S.;
Lee, H. K.;
Park, J. Y.;
Hong, S. K.;
Lee, K.-U.

Publication type:

Article

Glucose-insulin-potassium treatment in combination with dipyridamole inhibits ischaemia-reperfusion-induced damage.

Published in:

Diabetologia, 2001, v. 44, n. 12, p. 2165, doi. 10.1007/s001250100025

By:

Bertuglia, S.;
Giusti, A.;
Fedele, S.;
Picano, E.

Publication type:

Article

Works matching IS 0012186X AND DT 2001 AND VI 44 AND IP 12

5-aminoimidazole-4-carboxy-amide-1-β-D-ribofuranoside treatment ameliorates hyperglycaemia and hyperinsulinaemia but not dyslipidaemia in KKA<sup>y</sup>-CETP mice.

A choice of death – the signal-transduction of immune-mediated beta-cell apoptosis.

The author's reply.

The author's reply.

An economic model of the long-term health care burden of Type II diabetes.

Comment– to: Benhamou PY et al. (2001) Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999–2000). Diabetologia 44: 859–864.

Human adipose tissue glucose uptake determined using [<sup>18</sup>F]-fluoro-deoxy-glucose ([<sup>18</sup>F]FDG) and PET in combination with microdialysis.

Changes in physical activity are associated with changes in metabolic cardiovascular risk factors.

Oxidative stress impairs nuclear proteins binding to the insulin responsive element in the GLUT4 promoter.

Insulin-like growth factor 2 (IGF2 ) and IGF-binding protein 1 (IGFBP1) gene variants are associated with overfeeding-induced metabolic changes.

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients.

Clusterin expression during regeneration of pancreatic islet cells in streptozotocin-induced diabetic rats.

Comment– to: W. K. Waldhausl (2001) Finally we have arrived in a new millennium. Diabetologia 44: 1–2.

Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study.

Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus.

Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.

Comment– to: F. M. Nakhoul et al. (2001) Haptoglobin phenotype and diabetes. Diabetologia 44: 602–604.

Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects.

Islet cell autoimmunity and mitochondrial DNA mutation in Korean subjects with typical and atypical Type I diabetes.

Glucose-insulin-potassium treatment in combination with dipyridamole inhibits ischaemia-reperfusion-induced damage.